Allogene Therapeutics
Omid Abtahi, CPIM, is a seasoned professional in supply chain management with extensive experience in the biopharmaceutical industry. Currently serving as Senior Manager and Head of Clinical Supply Chain at Allogene Therapeutics since January 2021, Omid has previously held various roles at Genentech from 2011 to 2021, including Clinical & Commercial Production Planner/Scheduler and Maintenance Scheduler/Planner. Early career experience includes positions as a QC Associate and Documentation Specialist at Genentech, as well as a Pharmacy Technician at CVS Pharmacy. Omid holds a Bachelor of Science degree in Physiology and Biology from UC Santa Barbara, along with coursework in Biology, Chemistry, and Physiology from De Anza College.
This person is not in any teams
This person is not in any offices
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.